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Sulfation of tyrosine is a common posttranslational
modification of secreted proteins that influences
numerous physiological and pathological processes.
Studies of tyrosine sulfation have been hindered by
the difficulty of introducing sulfate groups at specific
positions of peptides and proteins. Here we report
a general strategy for synthesis of peptides contain-
ing sulfotyrosine at one or more specific position(s).
The approach provides a substantial improvement
in both yield and convenience over existingmethods.
Using synthetic sulfopeptides derived from the che-
mokine receptor CCR3, we demonstrate that sulfa-
tion enhances affinity for the chemokine eotaxin by
7-fold or more than 28-fold, depending on which
of two adjacent tyrosine residues is sulfated. The
synthetic methodology will substantially enhance
efforts to understand the functional and structural
consequences of protein tyrosine sulfation.
INTRODUCTION
Tyrosine sulfation is an increasingly recognized posttranslational
modification of secreted and integral membrane proteins, play-
ing important roles in blood coagulation, leukocyte adhesion
and trafficking, hormonal regulation, retroviral and parasitic
infection, and the humoral immune response (Kehoe and Ber-
tozzi, 2000; Seibert and Sakmar, 2008). Leukocyte trafficking
and blood cell infection by both HIV-1 and the malarial parasite
Plasmodium vivax are mediated by sulfated tyrosine residues
in the amino-terminal extracellular regions of chemokine recep-
tors (Farzan et al., 1999, 2000, 2002; Choe et al., 2005; Preobraz-
hensky et al., 2000; Liu et al., 2008). Remarkably, HIV-1 inhibitory
antibodies incorporate sulfotyrosine residues in their comple-
mentarity-determining regions, thereby mimicking recognition
of HIV surface glycoprotein gp120 by chemokine receptors
(Dorfman et al., 2006; Huang et al., 2007). Similarly, proteins
and peptides containing tyrosine-sulfated regions of chemokine
receptors can inhibit HIV infection (Cormier et al., 2000; Farzan
et al., 2002), P. vivax infection (Choe et al., 2005), and/or chemo-Chemistry & Biology 16, 153kine binding (Choe et al., 2005; Fong et al., 2002). Consequently,
there is considerable interest in determining the roles played by
specific sulfotyrosine residues in recognition of chemokines and
pathogen proteins.
The presence of sulfotyrosine in expressed proteins can be
readily demonstrated by radioactive sulfate-labeling and by
functional characterization under conditions that promote or
inhibit enzymatic sulfation or promote sulfate hydrolysis.
However, identification of the specific residues that are sulfated
and elucidation of their functional roles is more challenging. One
common approach is site-directed mutagenesis (typically Tyr/
Phe mutations) of the putatively sulfated residues (Farzan et al.,
1999; Choe et al., 2005; Fong et al., 2002), but these experiments
report on the roles of themutated residues rather than directly on
the roles of the sulfate moieties themselves. In favorable cases, it
is possible to introduce sulfate groups site-specifically by in vitro
enzymatic catalysis (Veldkamp et al., 2006). However, enzymatic
sulfation frequently yields a complex mixture of products that
may be difficult to separate (Seibert et al., 2002). In order to study
the functions of specific sulfate groups, it is therefore advanta-
geous to complement themutational and enzymatic approaches
by using synthetic peptides containing sulfate groups on specific
tyrosine residues.
To date, the synthesis of tyrosine-sulfated peptides, particu-
larly those incorporating more than one sulfotyrosine residue,
has been a considerable challenge. Available synthetic methods
may be classified according to twomajor approaches: the chem-
ical sulfation of peptides after they have been synthesized, or the
incorporation of tyrosine sulfate monoesters during peptide
synthesis (Seibert and Sakmar, 2008). However, both of these
approaches have major limitations that have prevented them
frombeing broadly useful. The chemical sulfation of tyrosine resi-
dues afterpeptide synthesis suffers from the lowspecificity of sul-
fation reagents, the need for special protecting group strategies,
and the difficulty of achieving resin cleavage and side chain de-
protection without degradation of the acid-labile tyrosine sulfate
monoesters. Furthermore, the chemical sulfation of multiple tyro-
sine residues, especially in largerpeptides, cansuffer from incom-
plete reactionswithsulfating reagents. Thus, chemical sulfationof
peptides is generally time-consuming, low-yielding, and limited in
scope. A more general approach is the incorporation of tyrosine
sulfate monoesters, such as FmocTyr(SO3Na)OH, during solid-
phase peptide synthesis (Penke and Nyerges, 1991; Kitagawa–161, February 27, 2009 ª2009 Elsevier Ltd All rights reserved 153
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elongation of the resulting peptide can be sluggish (Leppanen
et al., 2000), and attempts to incorporate multiple sulfotyrosine
residues into a peptide have been plagued by poor resin swelling
and the need for extended coupling times (Young and Kiessling,
2002). Furthermore, this approach also suffers from incomplete
resin cleavage and side-chain deprotection as well as some
hydrolysis of sulfotyrosine during TFA treatment, thus frequently
resulting in low overall yields of the desired peptides.
In this article, we propose a broadly applicable method for the
synthesis of tyrosine-sulfated peptides. By synthesis of previ-
ously studied peptides, we demonstrate the advantages of this
new method over existing approaches. In addition, by applying
the new method to peptides derived from the N-terminal region
of a chemokine receptor, we demonstrate that chemokine
recognition is sensitively dependent on both the presence and
the specific position of sulfotyrosine residues.
RESULTS AND DISCUSSION
Peptide Synthesis Strategy
The major difficulty of incorporating sulfotyrosine derivatives
during peptide synthesis is the instability of the tyrosine sulfate
monoester, especially under acidic conditions. We have recently
described the development of acid-stable alkyl protecting
groups for sulfate monoesters (Simpson and Widlanski, 2006).
In the work presented here, we utilized the neopentyl protecting
group for sulfate monoesters in the high-yielding synthesis of
tyrosine-sulfated peptides. The general strategy involves the
incorporation of a neopentyl-protected sulfate monoester of
tyrosine into a growing peptide chain (Figure 1). Resin cleavage
and deprotection of the completed peptide with TFA can be
achieved with minimal degradation of the protected sulfate
monoesters and the neopentyl group can be removed under
mild conditions to reveal a sulfotyrosine residue.
Synthesis of the Protected Sulfotyrosine Monomer
For the production of tyrosine-sulfated peptides by this strategy,
the requisite Fmoc-protected sulfotyrosine monomer was
synthesized in high overall yield (Figure 2). A protected tyrosine
derivative was treated with neopentyl chlorosulfate (NPCS) to
produce sulfate monoester 1 in 94% yield. Treatment of this
compound with 90% aqueous TFA removed Boc and t-butyl
groups, and an Fmoc protecting group was installed by stirring
the resulting compoundwithN-(9-fluorenylmethoxycarbonyloxy)
succinimide in dioxane and 10% aqueous sodium carbonate.
Purification by column chromatography gave compound 2 as
a white solid in 70% yield for the two combined steps. Benzylox-
ycarbonyl (Cbz) and benzyl protecting groups were not used in
this synthesis as previously reported (Simpson and Widlanski,
2006) because the removal of these groups under hydrogenoly-
sis conditions (Pd/C and H2) results in partial reduction (10%)
of the neopentyl-protected sulfate monoester of tyrosine to
phenylalanine. The reduction product cannot be easily separated
from the desired protected sulfate monoester.
Synthesis of Sulfotyrosine-Containing Peptides
We first tested the proposed synthesis strategy by preparing two
tyrosine-sulfated peptides that had been previously synthesized154 Chemistry & Biology 16, 153–161, February 27, 2009 ª2009 Elsby other methods: peptide 4, corresponding to residues 5–12 of
the cell adhesion molecule P-selectin glycoprotein ligand-1
(PSGL-1), and peptide 6, the human digestive hormone chole-
cystokinin (CCK)-12 (Figure 3). Standard diisopropylcarbodii-
mide-hydroxybenzotriazole protocols were used in the manual
or automated coupling of all Fmoc amino acids and the coupling
of tyrosine derivative 2 required neither special conditions nor
extended reaction times. Deblocking of Fmoc groups after
each coupling was accomplished by treatment with 20% piper-
idine. Although standard resins should be useful in this strategy,
the highly acid-sensitive 2-chlorotrityl resin was utilized in the
synthesis of peptide acids and the Sieber amide resin in the
synthesis of a peptide amide. These resins allow for quantitative
cleavage and convenient isolation of fully protected peptides
with 1%–3% TFA in dichloromethane. Following detachment of
the protected peptides, side-chain deprotection was achieved
by treatment with 95% TFA and scavengers at room
Figure 1. General Strategy for the Chemical Synthesis of Tyrosine-
Sulfated Peptides
SPPS represents solid-phase peptide synthesis; PG, side-chain protecting
group; nP, neopentyl.evier Ltd All rights reserved
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mained intact during these steps, with little or no degradation.
Neopentyl groups can be removed by treatment with unhin-
dered nucleophiles in a hot polar aprotic solvent. However, an
unanticipated result led to the discovery of milder and more
convenient conditions for deblocking. When the neopentyl-pro-
tected PSGL-1 peptide 3 was dissolved in aqueous ammonium
acetate, loss of the neopentyl group and preservation of the
resulting sulfate monoester was observed. Treatment with
aqueous sodium acetate produced a similar result, whereas
treatment with aqueous ammonium chloride resulted in precipi-
tation of the peptide. Although neopentyl protecting groups are
exceedingly stable in organic solvents, they appear to be
susceptible to acid-catalyzed solvolysis in polar protic solvents.
Indeed, acetolysis of neopentyl sulfonates proceeds via an as-
sisted SN1 reaction with methyl participation and rearrangement
(Ando et al., 1976). Thus, crude neopentyl-protected sulfotyro-
sine peptides 3 and 5 (Figure 3) were dissolved in a minimum
amount of dimethylsulfoxide, diluted with 1-2 M ammonium
acetate and placed in a 37C water bath for 6–12 hr. The result-
ing sulfate monoesters are stable in ammonium acetate buffer
(pH 7) and were loaded directly onto a reversed-phase high-
performance liquid chromatography (RP-HPLC) column for
purification.
Using these procedures, the monosulfated PSGL-1-derived
peptide 4 was produced in 98% overall yield based on resin
loading. In contrast, a reported synthesis of the N-acetylated
form of this peptide was accomplished in 5% overall yield using
chemical sulfation with sulfur trioxide/dimethyl formamide
complex (Young and Kiessling, 2002); N-terminal acetylation
was required to avoid the formation of a sulfamate upon treat-
Figure 2. Synthesis of the Protected Sulfo-
tyrosine Monomer
NPCS represents neopentyl chlorosulfate; nP,
neopentyl.
ment with sulfur trioxide. Similarly, a
peptide amide, CCK-12 sulfate 6, was
produced in 85% overall yield based on
resin loading. This peptide has previously
been synthesized via the incorporation of
FmocTyr(SO3Na)OH during solid-phase
synthesis (Kitagawa et al., 2001). Appar-
ently, the reported yield of 26% from the
protected-peptide resin does not include
the yield of coupling steps. Thus, for both
peptides 4 and 6, the approach used in
the present work represents a substantial
improvement over existing methods for
the synthesis of sulfotyrosine-containing
peptides.
Peptides Derived from Chemokine
Receptor CCR3
We have used this peptide synthesis
strategy to explore the role of tyrosine
sulfation in recognition of the chemokine
eotaxin by its receptor CCR3. CCR3 is expressed primarily on
eosinophils, basophils, and Th2 cells, and activation of CCR3
by eotaxin regulates the recruitment of these cell types in allergic
responses and parasitic infections (Jose et al., 1994; Rankin
et al., 2000; Yawalkar et al., 1999). In addition, CCR3 can support
HIV infection in vitro, although its function in HIV pathology is not
well established (Choe et al., 1996; He et al., 1997). The amino-
terminal extracellular region of CCR3 is sulfated when expressed
in HeLa cells as a fusion to the Fc domain of immunoglobulin
IgG1 (Farzan et al., 1999). This region contains two consecutive
tyrosine residues (Tyr-16 and Tyr-17) sequentially adjacent to
acidic residues, a common feature of tyrosine sulfation sites
(Figure 3). Based on comparisons of sequence context with
known sulfated and nonsulfated tyrosines, Tyr-17 is strongly pre-
dicted to be sulfated, and Tyr-16 is considered more likely than
not to be sulfated (Liu et al., 2008). A 35-residue nonsulfated
peptide corresponding to the complete N-terminal region (i.e.,
preceding the first transmembrane helix) binds to eotaxin with
an equilibrium dissociation constant (Kd) of 80 ± 38 mM (Ye
et al., 2000). Nuclear magnetic resonance (NMR) experiments
indicated that the central region of this peptide is involved in
the interaction with eotaxin and a truncated, nonsulfated peptide
(residues 8–23) binds to eotaxin with a dissociation constant of
about 136 ± 23 mM, only slightly weaker than the full-length
N-terminal peptide (Ye et al., 2000). Considering that this shorter
peptide encompasses the two putative tyrosine sulfation sites,
we hypothesized that sulfation of this peptide at one or both
positions would substantially enhance the affinity of chemokine
binding. To test this hypothesis, we synthesized four 16-mer
peptides (Figure 3) corresponding to residues 8–23 of CCR3
with sulfation on each of the tyrosine residues (peptides Su16Chemistry & Biology 16, 153–161, February 27, 2009 ª2009 Elsevier Ltd All rights reserved 155
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without sulfation (Su0).
The nonsulfated peptide (Su0) was synthesized using the solid
phase methods described above, except that double or triple
couplings of the final three N-terminal residues (T10, E9, and
V8) were required due to the slow rate of the coupling reactions
at these positions. Peptide Su0 (7) was obtained in 55% overall
yield. The three neopentyl-protected sulfotyrosine peptides 8,
10, and 12 were synthesized in the same manner, and the sulfo-
tyrosine residues were deprotected by dissolving the peptides in
aqueous ammonium acetate and heating to 37C to yield the
desired sulfated peptides Su16 (9), Su17 (11), and Su1617 (13)
in 68%, 72%, and 65% overall yields, respectively. Despite the
need for the final sulfate monoester deprotection step and
the use of the bulky neopentyl protecting groups during the
synthesis, the mono- and bis-sulfated peptides were obtained
in higher yield than the corresponding nonsulfated peptide,
further demonstrating the utility of the synthesis strategy.
Eotaxin Binding by CCR3-Derived Peptides
Binding of each peptide to eotaxin was monitored by collecting
1H-15N correlation NMR spectra of uniformly 15N-enriched eo-
taxin in the presence of increasing concentrations of each unla-
beled peptide (Figures 4A–4C). For each peptide, the observed
changes in eotaxin chemical shifts were fit globally for all reso-
nances that shifted in response to peptide binding, yielding the
equilibrium dissociation constant (Kd) for that peptide (Figures
Figure 3. Sequences and Yields of the Peptides Synthesized in this
Study
Neopentyl-protected sulfotyrosine residues are highlighted in bold green, sul-
fotyrosine residues are highlighted in bold red. Each indicated yield is the
overall percent yield of the final tyrosine-sulfated peptide based on initial resin
loading.156 Chemistry & Biology 16, 153–161, February 27, 2009 ª2009 Else4D–4F). In agreement with our previous observations (Ye et al.,
2000), Su0 bound to eotaxin with an equilibrium dissociation
constant (Kd) of 140 ± 40 mM and induced concentration-depen-
dent 1HN chemical shift changes of 0.01–0.04 ppm for a small
number (8) of amide resonances (Figure 4G). In contrast, Su17
bound to eotaxin with a 7-fold enhanced affinity (Kd = 22 ± 4 mM)
and induced considerably larger chemical shift changes of the
same amide resonances as well as several additional reso-
nances (Figure 4G). Interestingly, Su16 and Su1617 bound to eo-
taxin too tightly for the dissociation equilibrium constants to be
determined from chemical shift changes under the conditions
of the NMR experiment, indicating that the Kd values for these
interactions are less than 5 mM. Thus, the influence of tyrosine
sulfation on chemokine binding affinity is not only substantial but
also dependent on the specific position of the sulfate group. This
result raises the possibility that regulation of sulfation pattern
might be an effective mechanism for regulating the chemokine
affinity and responsiveness of chemokine receptors.
The 7-fold to more than 28-fold affinity enhancements
observed for the CCR3-derived peptides compare favorably
with those observed previous for sulfated peptides derived
from the N-terminal regions of other chemokine receptors.
Fong et al. reported that sulfation of a single Tyr residue in a
peptide from receptor CX3CR1 provided a 10-fold enhance-
ment of binding affinity for the chemokine fractalkine (Fong
et al., 2002). Similarly, Duma et al. found that a bis-sulfated
peptide derived from the N-terminal region of chemokine
receptor CCR5 bound stoichiometrically to the chemokine
RANTES (at 200 mM concentration), indicating a Kd value lower
than 20 mM in comparison with 168 mM for the corresponding
unsulfated peptide (Duma et al., 2007); the fitted Kd value for
the sulfated peptide was 1.2 mM. In addition, Veldkamp et al.
observed a 3.5-fold enhancement of binding affinity for the
chemokine SDF-1a upon sulfation of a single Tyr residue in an
N-terminal peptide from chemokine receptor CXCR4 (Veldkamp
et al., 2006) and a further enhancement of affinity upon sulfation
of three Tyr residues in the same peptide (Seibert et al., 2008).
Considering that chemokines are generally highly basic, it is
perhaps not surprising that their interactions with receptor
peptides should be enhanced by the addition of negative
charges to those peptides. However, previous mutational
studies of sulfated Tyr residues in chemokine receptors (Farzan
et al., 2002; Fong et al., 2002; Bannert et al., 2001) have shown
that interactions with chemokines are sensitive to the specific
Tyr residue that has been replaced, suggesting that the position,
rather than merely the presence, of sulfate is important. The
present results support this conclusion by demonstrating that
substantial but different enhancements of chemokine affinity
result from sulfation at each of two distinct positions.
Possible Sulfotyrosine Binding Sites
Previous NMR studies (Ye et al., 2000; Skelton et al., 1999; Clubb
et al., 1994; Mayer and Stone, 2000) have indicated that
N-terminal peptides from chemokine receptors interact with
the surface of their cognate chemokines defined by residues in
the N-loop and b2-b3 hairpin structural elements (structural
elements are shown in Figures 5A and 5B); we refer to this
surface as the ‘‘front face’’ of the chemokine (the face shown in
Figures 5A, 5C, and 5E). The NMR titration data presented hereinvier Ltd All rights reserved
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(A–C) Expanded regions of the 1H-15N correlation (HSQC) spectrum of 15N-labeled eotaxin containing the backbone amide peaks for residues Q21 (A), S25 (B),
and K47 (C). Each region is shown in the absence of peptide (gray contour in each of the four panels) and in the presence of 0, 0.6, 1, 2, and 4 equivalents of Su0
(blue contours), Su16 (red contours), Su17 (cyan contours), and Su1617 (green contours) in separate panels. Arrows indicate the direction of peak movement.
(D–F) Graphs showing the change in backbone 1HN chemical shift for Q21 (D), S25 (E) and K47 (F) as a function of the molar ratio of added peptide to
15N-labeled
eotaxin. Uncertainties in 1HN chemical shifts are approximately 0.004 ppm. Solid lines represent the fitted binding curves obtained separately for each peptide by
global analysis of all the binding data for that peptide (see text for details). Data and fitted curves are colored for each peptide as in (A–C).
(G) Bar graph showing the maximum changes in backbone 1HN chemical shift observed for specific residues of eotaxin upon addition of Su0 (blue), Su16 (red),
Su17 (cyan), and Su1617 (green); data are shown for all residues for which significant changes in chemical shifts were observed upon binding to one or more
peptide(s). Uncertainties in maximum shifts are approximately 0.004 ppm. The positions of secondary structure elements are indicated schematically at the
top of the graph.provide insights into the possible binding sites for the peptide
sulfate groups on this surface of eotaxin (Crump et al., 1998).
Chemical shift data were obtained for 28 of 65 backbone NH
groups in eotaxin, predominantly located in the secondary struc-
ture elements (Figure 4G); other NH groups were not observed
due to either resonance overlap, conformational exchange
broadening, or fast exchange with solvent. In the absence of
sulfation (peptide Su0), the largest chemical shift changes areChemistry & Biology 16, 153observed for residues Lys-17,Gln-21, andTrp-57 (blue in Figures
5C and 5D and Figure S20), suggesting that the peptide comes
into contact with the top part of the front face, possibly extending
toward the a helix. Sulfation of each tyrosine residue results in
additional chemical shift changes for a different (but overlapping)
set of residues and the changes observed for peptide Su1617 are
generally similar to those observed for one or both of the mono-
sulfated peptides (Figure 4G).–161, February 27, 2009 ª2009 Elsevier Ltd All rights reserved 157
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Proposed Locations of Bound Sulfotyrosine
Each panel shows front (left) and back (right) views
of the structure.
(A and B) Ribbon representation with the locations
of structural elements indicated.
(C and D) Ribbon representation with residues
showing the largest shifts upon binding to Su0
colored blue and residues that show substantial
additional shifts upon binding to Su16 and Su17
colored red and cyan, respectively.
(E and F) Surface electrostatic potential represen-
tations (blue represents positive, red is negative)
showing the proposed location of the Su16 sulfate
group (red circle) and a possible location of the
Su17 sulfate group (cyan circle).158 Chemistry & Biology 16, 153–161, February 27, 2009 ª2009 Elsevier Ltd All rights reserved
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to peptide Su0) for the backbone amide resonances of Leu-23,
Thr-43, and Lys-47 (red in Figures 5C, 5D, and S20). These three
residues are coupled to each other through a series of cross-
strand hydrogen bonds at the right-hand end of the b sheet,
near the b2-b3 hairpin turn and this region of the structure
includes a cluster of positively charged residues (Arg-22, Lys-44,
and Lys-47), suggesting that this cluster forms the binding site
for sulfotyrosine-16 of the CCR3 peptide (indicated by the red
oval in Figure 5E). In previous studies of interactions between
chemokines and sulfotyrosine-containing peptides, the equiva-
lent residue to Lys-47 (Arg-47 in both SDF-1a and RANTES)
has been implicated as a binding site for the sulfate group
(Veldkamp et al., 2006; Duma et al., 2007). Thus, this might be
a conserved sulfotyrosine recognition element on chemokine
surfaces.
In contrast to the observations with Su16, sulfation of Tyr-17
causes substantial shifts (in addition to those caused by Su0)
for the backbone amide resonances of Glu-24, Ser-25, and
Ile-49 (cyan in Figures 5C, 5D, and S20). These three residues
are located in the central region of the b sheet and their back-
bones are connected to each other, via Phe-41 and Lys-42,
through a series of cross-strand hydrogen bonds. Thus, the
chemical shift changes for these residues are likely to result
from interaction of sulfotyrosine-17 with either the front or back
face of the b sheet, and adjacent regions of the structure. The
back face (Figure 5F) includes several positively charged resi-
dues (Arg-27, Lys-42, Lys-44, Lys-68, and Lys-73) and a
substantial patch of negative potential resulting from acidic
residues (Glu-24 and Asp-48). If sulfotyrosine-16 binds in the
region discussed above, interaction of sulfotyrosine-17 with
the back face would require that the peptide chain forms a tight
turn between sulfotyrosine residues 16 and 17 and that the chain
orientation is substantially different from that found previously for
the complex of interleukin-8 (IL-8) with a peptidomimetic derived
from its receptor CXCR1 (Skelton et al., 1999) and for the
complex of SDF-1 with a CXCR4 peptide (vide infra) (Veldkamp
et al., 2008). Alternatively, if sulfotyrosine-17 is positioned on
the front face of eotaxin, it could potentially interact with the
side chains of b3-strand residue Ile-49, on the floor of the hydro-
phobic channel, and N-loop residue Arg-16, on the chemokine
surface, in the region indicated by the cyan circle in Figure 5E.
Formation of these interactions would be consistent with the
peptide chain being extended in an orientation similar to that
found for the CXCR1/IL-8 and CXCR4/SDF-1 interactions (Skel-
ton et al., 1999; Veldkamp et al., 2008). Recently, Veldkamp et al.
have reported the structure of an obligate SDF-1 dimer bound to
a triply sulfatedN-terminal peptide fromCXCR4 (Veldkamp et al.,
2008). In this structure, sulfotyrosine-21 interacts with the site
proposed for sulfotyrosine-16 of the CCR3 peptide in the current
study (vide supra). In addition, residues 17-20 of the peptide form
a turn around the b3 strand of the chemokine allowing the amino-
terminal region of the peptide to extend across the dimer inter-
face; sulfotyrosine-12 interacts with the back of the b1 strand
of one monomer and sulfotyrosine-7 interacts with the a-helix
of the other monomer. The mode of interaction observed for
the CXCR4 peptide with SDF-1 is not possible for the CCR3
peptide binding to eotaxin because: (1) eotaxin was monomeric
under the condition of our study; (2) CC chemokines dimerize inChemistry & Biology 16, 153a structurally distinct manner from CXC chemokines; and (3) the
spacing of sulfotyrosine residues is quite different for CCR3
versus CXCR4. Thus, it appears that recognition of the tyro-
sine-sulfated N-terminal regions of receptors might differ
substantially between CC and CXC chemokines. Characteriza-
tion of these differences will require detailed structural analysis
of additional complexes.
SIGNIFICANCE
We have described a new strategy to enable the production
of sulfotyrosine-containing peptides in high yield and have
demonstrated the utility of the approach for obtaining
insights into sulfotyrosine recognition by proteins. The
synthetic strategy uses standard Fmoc solid-phase
synthesis procedures and, except for the neopentyl-pro-
tected sulfotyrosine derivative, no other specially protected
amino acids are required. In contrast to other methods, this
strategy has been applied in automated peptide synthesis
and should be scalable to the production of larger quantities
without difficulty.
The synthesis strategy described herein permits the facile
synthesis of differentially sulfated and multiply sulfated
peptides. Using this approach, we have demonstrated that
sulfation of a 16-residue peptide from the chemokine
receptor CCR3 enhances the affinity of this peptide for its
cognate chemokine by 7-fold or more than 28-fold, de-
pending on which of two adjacent tyrosine residues is
sulfated. Considering that the N-terminal regions of most
chemokine receptors contain multiple tyrosine residues
that are known or predicted to be sulfated, it is likely that
similar enhancements of affinity will be obtainable by site-
specific sulfation of peptides from other chemokine recep-
tors. More generally, the synthesis approach will enable
the functional roles of sulfate groups on tyrosine residues
to be determined for peptides derived from any sulfotyro-
sine-containing protein. Furthermore, the synthetic
approach could potentially be combined with native chemi-
cal ligation methods (Dawson et al., 1994), allowing access
to intact proteins with tyrosine sulfation at specific posi-
tions. Structural studies of such peptides and proteins in
complex with their binding partners will provide a detailed
understanding of sulfotyrosine recognition in numerous
protein families. In summary, by providing ready access to
site-specifically sulfated peptides, the synthesis approach
described herein will overcome a major barrier to studying
the biochemical function of tyrosine sulfation.
EXPERIMENTAL PROCEDURES
General Information
Resins were purchased from Novabiochem (EMD Biosciences) and Fmoc-
amino acid derivatives were purchased from Anaspec, Inc. Arginine residues
were protected with the 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl
(Pbf) group, and standard t-butyl and Boc protecting groups were used on
other amino acid side chains. Diisopropylcarbodiimide (DIPCDI), hydroxyben-
zotriazole (HOBt), and all other chemicals were of analytical grade and were
usedwithout further purification. Uniformly 15N-labeled eotaxin was expressed
and purified as described previously (Ye et al., 2000). Reactions were done in
flame-dried flasks under a dry nitrogen or argon atmosphere and using–161, February 27, 2009 ª2009 Elsevier Ltd All rights reserved 159
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Biosystems 433A Peptide Synthesizer. Manual peptide synthesis was per-
formed in Bio-Rad Poly-Prep chromatography columns. Flash column chro-
matography was performed with 60 A˚ 230–400 mesh silica gel. 1H and 13C
NMR spectra were recorded at 400 and 100 MHz, respectively. Fourier trans-
formed infrared spectra were recorded as neat liquids or as thin films (obtained
by evaporation from chloroform). High-resolution mass spectra were obtained
by the methods indicated.
Synthesis of Sulfotyrosine Monomer
N-(Tert-Butoxycarbonyl)-L-Tyrosine Tert-Butyl Ester
Neopentyl Sulfate (1)
N-(tert-butoxycarbonyl)-L-tyrosine tert-butylester (Schliengeretal., 2000) (6.9g,
20.4 mmol) was dissolved in 200 ml dry THF and the resulting solution was
cooled to75C in a dry ice/isopropanol bath. Sodium bis(trimethylsilyl)amide
(1.0 M solution in THF, 22.5 ml, 22.5 mmol, 1.1 Eq) was added dropwise to the
cooled solution and stirred for 2 min. Neat neopentyl chlorosulfate (Simpson
and Widlanski, 2006) (3.9 ml, 24.5 mmol, 1.2 Eq) was added quickly and the
reaction mixture allowed to warm to room temperature. Upon completion
(thin-layer chromatography), ethyl acetate and water were added. The organic
layer was separated and washed with 5% aqueous citric acid and brine, then
dried overMgSO4 and concentrated in vacuo. Purification by silica gel chroma-
tography (5/20%ethyl acetate in hexanes) gave 1 as clear viscous oil (9.39 g,
94%): 1HNMR (400MHz,MeOH-d4) d7.32 (d, J=8.4Hz, 2H), 7.26 (d, J=8.8Hz,
2H), 4.25 (dd, J = 6.4, 8.4 Hz, 1H) 4.11 (s, 2H), 3.08 (dd, J = 6.4, 13.6 Hz, 1H),
2.94 (dd, J = 8.8, 13.6 Hz, 1H), 1.40 (s, 9H), 1.39 (s, 9H), 0.98 (s, 9H); 13C
NMR (100 MHz, MeOH-d4) d 172.51, 157.54, 150.42, 138.09, 131.94, 122.06,
84.42, 82.81, 80.46, 56.83, 38.09, 32.69, 28.70, 28.21, 26.24; IR (film) 2976,
1716, 1505, 1409, 1393, 1368, 1208, 1153, 965; HRMS (EI) m/z calcd for
C23H38NO8S (M+H
+) 488.2313, found 488.2299.
N-(9-Fluorenylmethoxycarbonyl) L-Tyrosine Neopentyl Sulfate (2)
tert-Butyl N-(tert-butoxycarbonyl)-L-tyrosine neopentyl sulfate 1 (9.30 g,
19.07 mmol) was dissolved in 120 ml trifluoroacetic acid and 6 ml water. After
stirring solution for 1 hr, TFA and water were removed in vacuo. The resulting
residue was dissolved in 80 ml dioxane and 160 ml 10% aqueous Na2CO3.
N-(9-fluorenylmethoxycarbonyloxy)-succinimide (7.39 g, 21.0 mmol, 1.1 Eq)
was added and the reaction was stirred overnight. Upon completion, the reac-
tion mixture was acidified (pH 3) and the product was extracted several times
with CH2Cl2. The combined extracts were dried overMgSO4 and concentrated
in vacuo. Purification by silica gel chromatography (2/10% methanol in
CH2Cl2) gave 2 as a white solid (7.38 g, 70%):
1H NMR (400 MHz, MeOH-d4)
d 7.73 (d, J = 7.6 Hz, 2H), 7.56 (m, 2H), 7.37-7.21 (m, 8H), 4.43 (m, 1H),
4.30-4.19 (m, 2 H), 4.11 (t, J = 6.8 Hz, 1H), 4.04 (s, 2H), 3.23 (dd, J = 4.6, 14 Hz,
1H), 2.96 (dd, J = 9.6, 14 Hz, 1H), 0.904 (s, 9H); 13C NMR (100 MHz, MeOH-d4)
d 174.69, 158.23, 150.48, 145.14, 142.47, 138.23, 131.90, 128.73, 128.11,
126.21, 122.02, 120.88, 84.52, 67.88, 56.49, 48.23, 37.78, 32.64, 26.15; IR
(film) 2961, 1690, 1575, 1504, 1406, 1206, 1150, 1049, 960, 883; HRMS (ESI)
m/z calcd for C29H32O8NS (M+H
+) 554.1849, found 544.1858.
Synthesis of Tyrosine-Sulfated Peptides: Representative Example
PSGL-1-Derived Peptide 4
Automated solid-phase peptide synthesis was done on a 0.1 mM scale
with a preloaded H-Phe-2-ClTrt resin (substitution = 0.60 mmol/g, 0.168 g,
0.10 mmol). Fmoc amino acids were incorporated by the DIPCDI-HOBt
coupling protocol in NMP: Fmoc amino acid (10 Eq), DIPCDI (10 Eq), and
HOBt (10 Eq). Amino acids were preactivated for 20 min, and resin coupling
was allowed to proceed for 40 min. After each coupling, Fmoc groups were
cleaved by a 3 min treatment with 20% piperidine in NMP, followed by a
second treatment for 11 min. After completion of the automated synthesis,
the protected peptide-resin was treated eight times with 1% TFA in CH2Cl2
(4 ml, 5 min each), with filtering after each treatment. The combined filtrate
was concentrated in vacuo to remove CH2Cl2 and the resulting residue was
treated with 90% TFA (5% methanol and 5% triisopropylsilane, 2.5 ml total)
at room temperature for 45 min. Diethyl ether was added and the resulting
precipitate was collected by centrifugation, washed once with diethyl ether,
and dried under vacuum to give the crude neopentyl-protected tyrosine-
sulfated peptide 3 (0.126 g). liquid chromatography mass spectrometry elec-160 Chemistry & Biology 16, 153–161, February 27, 2009 ª2009 Elstrospray-ionization (LCMS-ESI) (positive) m/z: calculated for C60H77N8O21S
1277.49 (M+H+), found 1278.0.
A portion of the crude peptide (0.050 g) was weighed into a large centrifuge
tube and dissolved with a minimum amount of dimethyl sulfoxide (0.5 ml). The
solution was then diluted to 50 ml with 2 M NH4OAc, capped, and placed in
a 37Cwater bath. After 6 hr, the fully deprotected peptide was loaded directly
onto a RP-HPLC column (2.2 3 25 cm Kromasil C18) equilibrated with 0.1 M
NH4OAc. The peptide was eluted with a gradient of 0.1 M NH4OAc and
CH3CN at a flow rate of 5 ml/min with absorbance detection at 225 nm. The
solvent was removed by lyophilization and the residue was dissolved in water
and again lyophilized to give 4 as a fluffy powder (0.048 g, 98% overall yield).
The sample exhibited a single peak on an analytical HPLC chromatogram.
LCMS-ESI (positive) m/z: calculated for C55H67N8O21S 1207.41 (M+H
+), found
1208.0 and m/z: calculated for C55H70N9O21S 1224.44 (M+NH4
+), found
1225.0.
NMR Titrations of Eotaxin with Peptides
Titrations of 15N-labeled eotaxin with synthetic peptides were performed using
initial samples of 15N-labeled eotaxin (50 mM, 600 ml) in 20 mM sodium acetate,
0.02% NaN3, and 10% D2O (pH 6.5). The peptide, in the same buffer, was
added in several aliquots from a 1 mM stock solution to give final molar ratios
([peptide]/[protein]) of 0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, 2, 2.5, 3, 4, and 5;
the final volume was 750 ml. For the initial sample and after each addition,
a gradient sensitivity-enhanced 15N-HSQC spectrum (Kay et al., 1992) was
recorded using spectral widths of 2,100 Hz and 10,000 Hz and 128 and
2048 complex data points in the 15N and 1H dimensions, respectively. Spectra
were recorded at 4Con a Varian NMRSystems 600MHz spectrometer equip-
ped with a triple-resonance Cold Probe. Chemical shifts were referenced to
external DSS.
Analysis of Binding Data
NMR data were processed using NMRPipe then visualized and analyzed using
Sparky. Spectral assignments were made by comparison to the published
assignments (Crump et al., 1998; Ye et al., 1999). 1HN chemical shift changes
(Dd) were measured in Sparky for each residue at each peptide concentration.
For each peptide, the data were then fit simultaneously, using the software
OriginPro 8, for all residues whose 1HN chemical shift changes in the final titra-
tion point wereR 0.02 ppm. Data were fit to the 1:1 binding equation:
Dd= 0:5Ddmax
0
@1+ r + Kd
Ce


ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1+ r +
Kd
Ce
2
4r
s 1
A
in which: Ddmax is the maximum change in chemical shift (fit individually for
each residue);Kd is the equilibrium dissociation constant (fit globally for all resi-
dues), r is the molar ratio ([peptide]/[protein]) at each titration point, and Ce is
the concentration of eotaxin at each titration point.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, twenty
figures, and one table and can be found with this article online at http://
www.cell.com/chemistry-biology/supplemental/S1074-5521(09)00005-2.
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